False
June 26, 2026
Industry experts discuss the trends reshaping biotech and biopharma development – from complex modalities and manufacturing pressures to AI, funding constraints, and the growing need to plan for commercialization earlier
9 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
June 23, 2026
Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development
4 min read
June 22, 2026
Why CDMO innovation is key to advancing next-generation oligonucleotide therapies
4 min read
June 22, 2026
A single infusion of Intellia’s in vivo gene-editing therapy reduced monthly hereditary angioedema attacks by 87 percent
3 min read
June 19, 2026
As BIO 2026 approaches, industry experts weigh in on the conversations likely to dominate the floor – from AI and funding pressures to manufacturing readiness, regulatory uncertainty, and the challenge of turning innovation into real-world impact
7 min read
June 18, 2026
With stricter regulations on the horizon, biopharma labs are being forced to rethink how they cool, store, and protect critical samples
5 min read
June 17, 2026
Why no single player can solve the scalability challenge alone
4 min read
June 16, 2026
The study points to a possible off-the-shelf cell therapy for solid tumors
2 min read
June 16, 2026
Researchers found gene therapy produced the highest modeled health benefit, but haploidentical stem cell transplantation offered better value at current prices
2 min read
June 15, 2026
The clinical-stage cancer biotech raised $670 million in an upsized Nasdaq debut, with a further $75 million expected from a concurrent Regeneron private placement
1 min read
June 15, 2026
Why patient voices must shape rare disease innovation
4 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
False
